RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ensysce Biosciences Stock

Ensysce Biosciences Liabilities 2024

Ensysce Biosciences Liabilities

3.03 M USD

Ticker

ENSC

ISIN

US2936024056

In 2024, Ensysce Biosciences's total liabilities amounted to 3.03 M USD, a -68.43% difference from the 9.6 M USD total liabilities in the previous year.

Ensysce Biosciences Aktienanalyse

What does Ensysce Biosciences do?

Ensysce Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Ensysce Biosciences's Liabilities

Ensysce Biosciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ensysce Biosciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ensysce Biosciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ensysce Biosciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ensysce Biosciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ensysce Biosciences stock

What is the level of liabilities of Ensysce Biosciences this year?

Ensysce Biosciences has a debt balance of 3.03 M USD this year.

What were the liabilities of Ensysce Biosciences compared to the previous year?

The liabilities of Ensysce Biosciences have increased by -68.43% dropped compared to the previous year.

What are the consequences of high debt for investors of Ensysce Biosciences?

High liabilities can pose a risk for investors of Ensysce Biosciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Ensysce Biosciences?

Low liabilities mean that Ensysce Biosciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Ensysce Biosciences affect the company?

An increase in liabilities of Ensysce Biosciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Ensysce Biosciences affect the company?

A decrease in the liabilities of Ensysce Biosciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Ensysce Biosciences?

Some factors that can influence the liabilities of Ensysce Biosciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Ensysce Biosciences so important for investors?

The liabilities of Ensysce Biosciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Ensysce Biosciences take to modify the liabilities?

To change its liabilities, Ensysce Biosciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Ensysce Biosciences pay?

Over the past 12 months, Ensysce Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ensysce Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Ensysce Biosciences?

The current dividend yield of Ensysce Biosciences is .

When does Ensysce Biosciences pay dividends?

Ensysce Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ensysce Biosciences?

Ensysce Biosciences paid dividends every year for the past 0 years.

What is the dividend of Ensysce Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ensysce Biosciences located?

Ensysce Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ensysce Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ensysce Biosciences from 10/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/24/2024.

When did Ensysce Biosciences pay the last dividend?

The last dividend was paid out on 10/24/2024.

What was the dividend of Ensysce Biosciences in the year 2023?

In the year 2023, Ensysce Biosciences distributed 0 USD as dividends.

In which currency does Ensysce Biosciences pay out the dividend?

The dividends of Ensysce Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ensysce Biosciences

Our stock analysis for Ensysce Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ensysce Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.